Location: Oviedo
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Oviedo
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors. Phase N/A · Hospital Universitario Central de Asturias · Spanish Oncology Genito-Urinary Group · NCT06724159 Spanish Series of Patients Treated With the Radionuclide Lutetium177 Phase N/A · Hospital Universitario Central de Asturias · Sociedad Española de Medicina Nuclear e Imagen Molecular · NCT04949282 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units NA · Hospital Universitario Central de Asturias · Poitiers University Hospital · NCT05686850 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Hospital Universitario Central de Asturias · Amgen · NCT07037433 Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice Phase N/A · Hospital Universitario Central de Asturias · Outcomes'10 · NCT07252765 Spanish Registry of Esophagogastric Cancer Phase N/A · Hospital Universitario Central de Asturias · Fundación Sociedad Española de Oncologia Médica · NCT04958720 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Phase N/A · Hospital Universitario Central de Asturias · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo) Phase N/A · Hospital Universitario Central de Asturias · Biobizkaia Health Research Institute · NCT07240038 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Phase N/A · Hospital Univ. Central de Asturias · Hoffmann-La Roche · NCT07284121 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined Phase 3 · Hospital Universitario Central de Asturias · Regeneron Pharmaceuticals · NCT06091865 Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery Phase 3 · Central University Hospital of Asturias · Octapharma · NCT04918173 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera Phase 3 · Hospital Universitario Central de Asturias · Eli Lilly and Company · NCT06937086 Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis NA · Hospital Universitario Central de Asturias · Grupo Español de Investigación en Diagnóstico y Tratamiento · NCT07465848 Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor Phase 2 · Hospital Universitario Central de Asturias-Medical Oncology · Merck Sharp & Dohme LLC · NCT04924075 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes Phase N/A · Hospital Universitario Central de Asturias · Bristol-Myers Squibb · NCT05489705 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy ( Phase 3 · Investigational Site Number : 7240005 · Sanofi · NCT06290128 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer Phase 3 · Hosp. Univ. Central de Asturias · Janssen Research & Development, LLC · NCT06319820 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop Phase 3 · Hospital Universitario Central de Asturias · Daiichi Sankyo · NCT06731478 Usefulness of PET-CT for Invasive Fungal Infection Phase N/A · Hospital Universitario Central de Asturias · Puerta de Hierro University Hospital · NCT05688592 A Mobile App to Reduce and/or Quit Cannabis Use NA · Faculty of Psychology, University of Oviedo · Alba González-Roz, PhD · NCT06733792 Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors Phase 2/Phase 3 · Hospital Universitario Central de Asturias · Exelixis · NCT06943755 CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL Phase 2 · Hospital Universitario Central de Asturias · GELLC (Grupo Español de Leucemia Linfocítica Crónica) · NCT06926205 Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) Phase 4 · Hospital Universitario Central de Asturias · Hospital Universitario de Fuenlabrada · NCT05250648 L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adu Phase 2/Phase 3 · Hospital Universitario Central de Asturias (HUCA) · Moleculin Biotech, Inc. · NCT06788756 A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia Phase 2 · Hospital Universitario Central de Asturias · Karyopharm Therapeutics Inc · NCT05980806 A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treat Phase 2 · Central University Hospital of Asturias · BioMarin Pharmaceutical · NCT06668805 A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Parti Phase 1/Phase 2 · Hospital Universitario Central de Asturias · Regeneron Pharmaceuticals · NCT05828511 Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults NA · H. Central de Asturias · PETHEMA Foundation · NCT04179929
Look up another city
Look up another condition